Skip to main content
Premium Trial:

Request an Annual Quote

GeneNews Hires Interim CFO; GenVault Taps Invitrogen Alumnus to Be Operations VP; BIO Names New Deputy Counsel; and Others

NEW YORK (GenomeWeb News) — GeneNews has hired Colin West as interim chief financial officer, the company said this week. He replaces Colin Martin, and GeneNews said it has already begun a search and expects to name a permanent CFO within the next three to six months.
West was formerly CEO and president of Richtree Market Restaurants, and he has served on the board of directors of both public and private companies. West has been a senior partner in an accounting firm and is a principal at Atticus Interim Management, an executive placement consulting firm.

The Biotechnology Industry Organization has hired Sandra Dennis to the post of deputy general counsel for healthcare regulatory affairs, the organization said this week.
Dennis recently was a partner focusing on US Food and Drug Administration and regulation at the law firm Morgan, Lewis and Bockius, and she has two decades experience working with BIO member-companies. Dennis also has experience at other law firms and was a television news anchor in South Carolina.

GenVault appointed Don O’Neil as its vice president of operations as of Jan. 2, the company said this week. In the position, O’Neill will oversee sales, manufacturing, and engineering operations at the DNA sample handling company.
O’Neill most recently was global business area director at Invitrogen, and before that he served at Illumina, Gravitron, Discovery Partners International, and Energy Science Laboratories.

Solazyme has appointed Arthur Grossman as chief of genetics. The Menlo Park, Calif.-based company said today. Grossman is a senior staff scientist at the Carnegie Institution and a professor of biological sciences at Stanford University.
Solazyme said Grossman will retain his academic positions but will split time with the company. At Solazyme Grossman will oversee R&D projects and development strategies. He was formerly chair of Solazyme’s scientific advisory board.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.